Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference Sep 9, 2016
Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams Sep 7, 2016
Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference Aug 23, 2016
Actinium Pharmaceuticals Granted SME Status by the European Medicines Agency; Reiterates Focus on EU Market Aug 9, 2016
Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Providing Update on Company Progress and Anticipated Milestones Aug 4, 2016
Actinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial Jul 20, 2016
Actinium Receives Assignment of Intellectual Property From Memorial Sloan Kettering Cancer Center Specific to Actinium's APIT Platform and the Use of Actinium-225 Jul 12, 2016
Actinium Pharmaceuticals to Sponsor Investigator Meeting for Pivotal Phase 3 SIERRA Trial for Iomab-B Jul 6, 2016
